RXRX vs MSFT: Which Stock is Better?
Side-by-side comparison of Recursion Pharmaceuticals Inc and Microsoft Corporation in 2026
RXRX
Recursion Pharmaceuticals Inc
$3.31
MSFT
Microsoft Corporation
$498.41
Key Metrics Comparison
| Metric | RXRX | MSFT | Winner |
|---|---|---|---|
| Market Cap | $1.75B | $3.71T | MSFT |
| P/E Ratio | N/A | 33.89 | MSFT |
| EPS (TTM) | $N/A | $14.08 | MSFT |
| Revenue Growth | 0.0% | 18.4% | MSFT |
| Gross Margin | 0.0% | 67.9% | MSFT |
Analyze RXRX
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is RXRX or MSFT a better investment?
Comparing RXRX and MSFT: Recursion Pharmaceuticals Inc has a market cap of $1.75B while Microsoft Corporation has $3.71T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between RXRX and MSFT?
RXRX (Recursion Pharmaceuticals Inc) and MSFT (Microsoft Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: RXRX or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: RXRX or MSFT?
MSFT has higher revenue growth at 18.4% vs 0.0% for RXRX.
Which company is more profitable: RXRX or MSFT?
Microsoft Corporation (MSFT) has higher gross margins at 67.9% compared to 0.0% for RXRX.
Which is the larger company: RXRX or MSFT?
Microsoft Corporation (MSFT) is larger with a market cap of $3.71T compared to $1.75B for RXRX.
Should I buy RXRX or MSFT in 2026?
Both RXRX and MSFT have investment merit. RXRX trades at $3.31 while MSFT trades at $498.41. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between RXRX and MSFT stock?
Key differences: Market Cap ($1.75B vs $3.71T), P/E Ratio (N/A vs 33.9x), Revenue Growth (0.0% vs 18.4%), Gross Margin (0.0% vs 67.9%).
Should I buy RXRX or MSFT in 2026?
The choice between RXRX and MSFT depends on your investment goals. MSFT shows higher revenue growth (18.4%). MSFT has better margins (67.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between RXRX and MSFT?
RXRX (Recursion Pharmaceuticals Inc) has a market cap of $1.75B, while MSFT (Microsoft Corporation) has a market cap of $3.71T. MSFT is the larger company by market value.